Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Peloton Names Its Latest Marketing Chief as Turnaround Project Continues
Market Updates

Peloton Names Its Latest Marketing Chief as Turnaround Project Continues

Peloton Interactive has named Megan Imbres chief marketing officer, making her the fourth marketing leader at the connected fitness company since 2020. Imbres, who most recently served as managing dir...

  • June 12, 2025 03:04 PM PDT
  • EODHD
Kalkine : Argan Maintain Its Return Momentum Long-Term NYSE Composite
Industrial Stocks

Kalkine : Argan Maintain Its Return Momentum Long-Term NYSE Composite

Highlights,Argan NYSE:AGX reports strong performance through efficient capital allocation,Return on capital employed reflects strategic internal resource management,Listed on NYSE Composite, reflecting industrial sector stability,Argan (NYSE:AGX), listed ...

Companies Warn Investors: Immigration Policy Poses Threat to Business
Market Updates

Companies Warn Investors: Immigration Policy Poses Threat to Business

President Trump’s deportation push is prompting more companies to warn investors that immigration policy could hurt their business. Nearly 90 consumer companies cited immigration in the first three mo...

  • June 12, 2025 03:01 PM PDT
  • EODHD
Kalkine : Global Payments Dividend Remain Sustainable on NYSE Composite
Industrial Stocks

Kalkine : Global Payments Dividend Remain Sustainable on NYSE Composite

Highlights,Global Payments Inc. (NYSE:GPN) announces next dividend distribution,Company continues financial alignment with distribution policies,GPN is a component of the,NYSE Composite index,Global Payments Inc. (NYSE:GPN) operates in the financial techn...

Neuralink files to raise $649M in financing
Market Updates

Neuralink files to raise $649M in financing

[Bar graph of floating cash - Wave pattern] PM Images * Tesla (NASDAQ:TSLA [https://seekingalpha.com/symbol/TSLA]) founder Elon Musk's neurotechnology company, Neuralink, has filed for a $649M equity...

  • June 12, 2025 02:56 PM PDT
  • EODHD
Klakine : Global Payments Dividend Remain Sustainable on NYSE Composite
Industrial Stocks

Klakine : Global Payments Dividend Remain Sustainable on NYSE Composite

Highlights,Global Payments Inc. (NYSE:GPN) announces next dividend distribution,Company continues financial alignment with distribution policies,GPN is a component of the,NYSE Composite index,Global Payments Inc. (NYSE:GPN) operates in the financial techn...

BlackRock’s ‘Bold, But Doable’ Targets Reflect a Changing Asset Manager
Market Updates

BlackRock’s ‘Bold, But Doable’ Targets Reflect a Changing Asset Manager

From their Manhattan headquarters on Thursday, top BlackRock leaders—including Chief Executive Larry Fink, who had just flown back to New York after a trip to the Middle East—lined up to discuss their...

  • June 12, 2025 02:52 PM PDT
  • EODHD
Kalkine : Can Claritev (CTEV) Sustain Momentum on the NYSE Composite
Market Updates

Kalkine : Can Claritev (CTEV) Sustain Momentum on the NYSE Composite

Highlights,Claritev Corporation (NYSE:CTEV) shows sharp movement across recent quarters,Positioned within the NYSE Composite, indicating relevance in diversified sectors,Revenue pattern gains attention despite absence of profitability,Claritev Corporation...

XTI Aerospace launches public offering of up to 3.96M shares, pre-funded warrants
Market Updates

XTI Aerospace launches public offering of up to 3.96M shares, pre-funded warrants

* XTI Aerospace (NASDAQ:XTIA [https://seekingalpha.com/symbol/XTIA]) is conducting a firm commitment public offering of up to 3.96M shares of common stock. * Shares are priced at $5.05 each. * Purchas...

  • June 12, 2025 02:40 PM PDT
  • EODHD
Kalkine: Can FDA Approval Reshape AbbVie’s Role In S&P 500
Healthcare Stocks

Kalkine: Can FDA Approval Reshape AbbVie’s Role In S&P 500

Highlights,AbbVie receives FDA approval to expand MAVYRET’s treatment scope,Pediatric hepatitis C now addressed within AbbVie’s therapy range,Part of the S&P 500 and NYSE Composite indices,AbbVie Inc. (NYSE:ABBV), a notable name in the,S&P 500,and,NYSE Co...